BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 16979240)

  • 21. CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b.
    Blom AM; Kask L; Dahlbäck B
    Mol Immunol; 2003 Jan; 39(10):547-56. PubMed ID: 12431388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.
    Gigli I; Fujita T; Nussenzweig V
    Proc Natl Acad Sci U S A; 1979 Dec; 76(12):6596-600. PubMed ID: 293746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of complement component C5: comparison of C5 convertases of the lectin pathway and the classical pathway of complement.
    Rawal N; Rajagopalan R; Salvi VP
    J Biol Chem; 2008 Mar; 283(12):7853-63. PubMed ID: 18204047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction with C4b-binding protein contributes to nontypeable Haemophilus influenzae serum resistance.
    Hallström T; Jarva H; Riesbeck K; Blom AM
    J Immunol; 2007 May; 178(10):6359-66. PubMed ID: 17475865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C3 convertase of human complement: enhanced formation and stability of the enzyme generated with nickel instead of magnesium.
    Fishelson Z; Müller-Eberhard HJ
    J Immunol; 1982 Dec; 129(6):2603-7. PubMed ID: 6923908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C3 requirements for formation of alternative pathway C5 convertase.
    Daha MR; Fearon DT; Austen KF
    J Immunol; 1976 Aug; 117(2):630-4. PubMed ID: 950465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enolase of Streptococcus pneumoniae binds human complement inhibitor C4b-binding protein and contributes to complement evasion.
    Agarwal V; Hammerschmidt S; Malm S; Bergmann S; Riesbeck K; Blom AM
    J Immunol; 2012 Oct; 189(7):3575-84. PubMed ID: 22925928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Proposed structure of the F' allotype of human CR1. Loss of a C3b binding site may be associated with altered function.
    Wong WW; Farrell SA
    J Immunol; 1991 Jan; 146(2):656-62. PubMed ID: 1670949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localization of the covalent C3b-binding site on C4b within the complement classical pathway C5 convertase, C4b2a3b.
    Kozono H; Kinoshita T; Kim YU; Takata-Kozono Y; Tsunasawa S; Sakiyama F; Takeda J; Hong K; Inoue K
    J Biol Chem; 1990 Aug; 265(24):14444-9. PubMed ID: 2387864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural basis and functional effects of the interaction between complement inhibitor C4b-binding protein and DNA.
    Okroj M; Jenkins HT; Herbert AP; Barlow PN; Blom AM
    Mol Immunol; 2008 Nov; 46(1):62-9. PubMed ID: 18715646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF).
    Seya T; Holers VM; Atkinson JP
    J Immunol; 1985 Oct; 135(4):2661-7. PubMed ID: 3161944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative importance of C4 binding protein in the modulation of the classical pathway C3 convertase in patients with systemic lupus erythematosus.
    Daha MR; Hazevoet HM; Hermans J; van Es LA; Cats A
    Clin Exp Immunol; 1983 Oct; 54(1):248-52. PubMed ID: 6604610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in alpha-chain of C4BP that selectively affect its factor I cofactor function.
    Blom AM; Villoutreix BO; Dahlbäck B
    J Biol Chem; 2003 Oct; 278(44):43437-42. PubMed ID: 12893820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1.
    Medof ME; Nussenzweig V
    J Exp Med; 1984 Jun; 159(6):1669-85. PubMed ID: 6233387
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formation of high-affinity C5 convertases of the alternative pathway of complement.
    Rawal N; Pangburn M
    J Immunol; 2001 Feb; 166(4):2635-42. PubMed ID: 11160326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Binding of activated C3b component with complement effector].
    Kozlov LV; Rostovtseva LI; Lomaka TS; Sutovskaia NS
    Bioorg Khim; 1985 Jun; 11(6):762-8. PubMed ID: 3849970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
    Sahu A; Kay BK; Lambris JD
    J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The complement regulator C4b-binding protein (C4BP) interacts with both the C4c and C4dg subfragments of the parent C4b ligand: evidence for synergy in C4BP subsite binding.
    Leung E; Blom AM; Clemenza L; Isenman DE
    Biochemistry; 2006 Jul; 45(27):8378-92. PubMed ID: 16819837
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement receptor is an inhibitor of the complement cascade.
    Iida K; Nussenzweig V
    J Exp Med; 1981 May; 153(5):1138-50. PubMed ID: 6910481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway.
    Møller-Kristensen M; Thiel S; Sjöholm A; Matsushita M; Jensenius JC
    Int Immunol; 2007 Feb; 19(2):141-9. PubMed ID: 17182967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.